A comparative analysis thus reveals that while antioxidant pathways (e.g., Nrf2, HO-1 induction) are central in neurodegenerative disorders and epilepsy, immune-modulatory effects (e.g., inhibition of NF-κB, cytokine regulation) are more pronounced under psychiatric and neurodevelopmental conditions. This evidence concerns the gene HMOX1 and epilepsy.